Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Lupski Lab, |
RCV000656083 | SCV000598581 | likely pathogenic | Complex cortical dysplasia with other brain malformations 1 | 2017-09-01 | criteria provided, single submitter | research | this variant was indentified in an individual with malformations of cortical development |
DASA | RCV001824143 | SCV002073749 | likely pathogenic | Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement | 2022-02-05 | criteria provided, single submitter | clinical testing | The c.136C>T;p.(Arg46Trp) missense variant has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 438582; PMID: 29269699; 29706646) - PS4_supporting. This variant is not present in population databases (rs1555625363; gnomAD; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2. The variant was assumed de novo; but without confirmation of paternity and maternity (PMID: 29269699; 29706646) - PM6. Missense variant in TUBB3 that has a low rate of benign missense variation and in which missense variants are a common mechanism of disease - PP2. Multiple lines of computational evidence support a deleterious effect on the gene or gene product - PP3. In summary, the currently available evidence indicates that the variant is likely pathogenic. |
Gene |
RCV002461261 | SCV002756622 | pathogenic | not provided | 2022-11-18 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; The majority of missense variants in this gene are considered pathogenic (HGMD); This variant is associated with the following publications: (PMID: 29706646, 29269699, 20829227) |
Department of Genetics, |
RCV003126774 | SCV003803900 | likely pathogenic | Developmental disorder | 2021-06-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002461261 | SCV004184625 | pathogenic | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | TUBB3: PS2:Very Strong, PM2, PS4:Moderate, PM5:Supporting, PP2, PP3 |
Invitae | RCV002461261 | SCV004296443 | uncertain significance | not provided | 2023-05-03 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TUBB3 protein function. ClinVar contains an entry for this variant (Variation ID: 438582). This missense change has been observed in individual(s) with clinical features of TUBB3-related conditions (PMID: 29269699, 29706646). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 46 of the TUBB3 protein (p.Arg46Trp). |